Flucytosine kinetics in subjects with normal and impaired renal function
- PMID: 688726
- DOI: 10.1002/cpt1978243333
Flucytosine kinetics in subjects with normal and impaired renal function
Similar articles
-
Pharmacokinetics of amphotericin B and flucytosine.Postgrad Med J. 1979 Sep;55(647):667-70. doi: 10.1136/pgmj.55.647.667. Postgrad Med J. 1979. PMID: 523358 Free PMC article.
-
Use of 5-fluorocytosine in patients with impaired renal function.Br Med J. 1973 Nov 17;4(5889):382-4. doi: 10.1136/bmj.4.5889.382. Br Med J. 1973. PMID: 4749757 Free PMC article.
-
Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.Clin Pharmacol Ther. 1999 Jan;65(1):21-8. doi: 10.1016/S0009-9236(99)70118-9. Clin Pharmacol Ther. 1999. PMID: 9951427
-
Pharmacokinetics and response to diazoxide in renal failure.Clin Pharmacokinet. 1977 May-Jun;2(3):198-204. doi: 10.2165/00003088-197702030-00004. Clin Pharmacokinet. 1977. PMID: 328207 Review.
-
Ofloxacin pharmacokinetics in chronic renal failure and dialysis.Clin Pharmacokinet. 1991 Nov;21(5):357-71. doi: 10.2165/00003088-199121050-00004. Clin Pharmacokinet. 1991. PMID: 1773550 Review.
Cited by
-
Clinical pharmacokinetics of systemic antifungal drugs.Clin Pharmacokinet. 1983 Jan-Feb;8(1):17-42. doi: 10.2165/00003088-198308010-00002. Clin Pharmacokinet. 1983. PMID: 6301738 Review. No abstract available.
-
Pharmacokinetics and pharmacodynamics in critically ill patients.World J Surg. 1987 Apr;11(2):210-7. doi: 10.1007/BF01656404. World J Surg. 1987. PMID: 3296480 Review. No abstract available.
-
Derivation of an in vivo drug exposure breakpoint for flucytosine against Candida albicans and Impact of the MIC, growth rate, and resistance genotype on the antifungal effect.Antimicrob Agents Chemother. 2006 Nov;50(11):3680-8. doi: 10.1128/AAC.00369-06. Epub 2006 Sep 5. Antimicrob Agents Chemother. 2006. PMID: 16954320 Free PMC article.
-
Therapeutic Drug Monitoring of Antifungal Agents in Critically Ill Patients: Is There a Need for Dose Optimisation?Antibiotics (Basel). 2022 May 12;11(5):645. doi: 10.3390/antibiotics11050645. Antibiotics (Basel). 2022. PMID: 35625289 Free PMC article. Review.
-
Activities and ultrastructural effects of antifungal combinations against simulated Candida endocardial vegetations.Antimicrob Agents Chemother. 2008 Jul;52(7):2367-76. doi: 10.1128/AAC.01557-07. Epub 2008 Apr 21. Antimicrob Agents Chemother. 2008. PMID: 18426896 Free PMC article.